We are live on ! Find out more
CE icon

Celanese

559 hedge funds and large institutions have $14.7B invested in Celanese in 2019 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 175 increasing their positions, 228 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

12% more capital invested

Capital invested by funds: $13.1B → $14.7B (+$1.6B)

5% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 64

0.94% more ownership

Funds ownership: 96.98%97.91% (+0.94%)

0% more funds holding

Funds holding: 558559 (+1)

23% less call options, than puts

Call options by funds: $28.4M | Put options by funds: $36.7M

23% less repeat investments, than reductions

Existing positions increased: 175 | Existing positions reduced: 228

Holders
559
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
12.26%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
67
Increased
175
Reduced
228
Closed
64
Calls
$28.4M
Puts
$36.7M
Net Calls
-$8.28M
Net Calls Change
-$23.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Grantham, Mayo, Van Otterloo & Co (GMO)
226
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$2.08M -$2.42M -21,500 -56%
GC
227
Guggenheim Capital
Illinois
$2.04M -$100K -889 -5%
ERSOT
228
Employees Retirement System of Texas
Texas
$2.03M +$1.87M +16,628 New
Voloridge Investment Management
229
Voloridge Investment Management
Florida
$2M +$1.84M +16,315 New
US Bancorp
230
US Bancorp
Minnesota
$1.98M +$2.93K +26 +0.2%
Neuberger Berman Group
231
Neuberger Berman Group
New York
$1.97M -$103K -914 -5%
WPW
232
Waldron Private Wealth
Pennsylvania
$1.91M +$1.76M +15,655 New
TAM
233
Tyers Asset Management
Texas
$1.9M -$2.15M -19,104 -55%
PIM
234
Penobscot Investment Management
Massachusetts
$1.9M +$62.5K +555 +4%
Federated Hermes
235
Federated Hermes
Pennsylvania
$1.87M -$316K -2,809 -16%
Mirae Asset Global Investments
236
Mirae Asset Global Investments
South Korea
$1.84M +$142K +1,263 +9%
CFMC
237
Curbstone Financial Management Corp
New Hampshire
$1.83M
RIM
238
Redpoint Investment Management
Australia
$1.79M
BAM
239
Blueshift Asset Management
New Jersey
$1.75M +$1.61M +14,308 New
NLGIA
240
Nippon Life Global Investors Americas
New York
$1.74M -$2.82M -24,990 -64%
MWP
241
MYCIO Wealth Partners
Pennsylvania
$1.73M +$1.24K +11 +0.1%
SO
242
STRS Ohio
Ohio
$1.7M +$17.8K +158 +1%
Cohen & Steers
243
Cohen & Steers
New York
$1.68M +$33.2K +295 +2%
PS
244
Pensionfund Sabic
Netherlands
$1.67M
HIMCH
245
Hartford Investment Management Co (HIMCO)
Connecticut
$1.64M -$60.2K -534 -4%
II
246
IFM Investors
Australia
$1.63M +$414K +3,676 +38%
LOAMU
247
Lombard Odier Asset Management (USA)
New York
$1.59M +$1.46M +13,000 New
FIM
248
Fruth Investment Management
Texas
$1.57M -$16.9K -150 -1%
SAM
249
Securian Asset Management
Minnesota
$1.56M -$33.8K -300 -2%
BIM
250
Baldwin Investment Management
Pennsylvania
$1.56M

CE Hedge Fund Activity: Q3 2019 in Review

559 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Celanese (CE) for Q3 2019, worth a combined $14.7B — up 12% from $13.1B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new CE positions and 64 closed out — a net gain of 3 holders — while 175 added to existing stakes and 228 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $204M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $69.7M.

  • 559 institutional investors held Celanese (CE) as of Q3 2019, up from 558 in Q2 2019.
  • Funds reported $14.7B of Celanese stock for Q3 2019, up 12% quarter-over-quarter.
  • 67 funds opened new Celanese positions in Q3 2019 and 64 closed out, a net change of +3 holders.
  • The largest Celanese buyer in Q3 2019 was Wellington Management Group, an estimated $204M added.
  • The largest Celanese seller in Q3 2019 was Fuller & Thaler Asset Management, an estimated $69.7M sold.

Based on aggregated 13F filings for Q3 2019.